Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Combined therapy in multiple sclerosis].

J A García-Merino1, M R Blasco-Quítez, P Ortiz-Benítez

  • 1Servicio de Neurología/Laboratorio de Neuroinmunología, Clínica Puerta de Hierro, Madrid, España. gmerino@meditex.es

Revista De Neurologia
|March 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Descriptive analysis of the electroencephalogram in Angelman syndrome].

Revista de neurologia·2021
Same author

Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement.

Neurologia·2020
Same author

12th Post-ECTRIMS Meeting: review of the novelties from the 2019 ECTRIMS Congress (II).

Revista de neurologia·2020
Same author

[12th Post-ECTRIMS Meeting: review of the novelties from the 2019 ECTRIMS Congress (I)].

Revista de neurologia·2020
Same author

[Recommendations for the use of cladribine tablets in recurring multiple sclerosis].

Revista de neurologia·2020
Same author

Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (II).

Revista de neurologia·2019
Same journal

The Correlation Between and Variability of Three Balance Scales in the Assessment of Balance Function in Patients With Ataxia.

Revista de neurologia·2026
Same journal

Surgical Treatment of an Aneurysm in the Subacute Stage of Hemorrhagic Moyamoya Disease: Aneurysm Resection Combined With STA-MCA Bypass: A Case Report.

Revista de neurologia·2026
Same journal

Mapping the Evidence: Central Sleep Apnea Syndromes During Sleep and Stroke-A Scoping Review.

Revista de neurologia·2026
Same journal

Developmental and Epileptic Encephalopathy Due to a Novel <i>ARHGEF9</i> Deletion Variant: Case Series of Two Siblings.

Revista de neurologia·2026
Same journal

P300 Event-Related Potentials as Cognitive Biomarkers in Neurological and Neuropsychiatric Disorders: A Systematic Review.

Revista de neurologia·2026
Same journal

[Effectiveness and Risk of Recurrence of Pulsed Radiofrequency in Trigeminal Neuralgia and Chronic Cluster Headache].

Revista de neurologia·2026
See all related articles

Combination therapy offers a promising strategy to improve multiple sclerosis treatment outcomes. This approach combines existing and novel drugs to enhance efficacy where single therapies fall short.

Area of Science:

  • Neurology
  • Pharmacology

Context:

  • Multiple sclerosis (MS) therapy has advanced with new drugs, but complete disease control remains elusive.
  • Some patients exhibit poor or no response to current single-drug treatments for multiple sclerosis.

Purpose:

  • To review approved multiple sclerosis therapies.
  • To examine the advantages and theoretical basis of drug combinations in multiple sclerosis.
  • To analyze clinical trial designs for combination therapy in relapsing forms of multiple sclerosis.

Summary:

  • This paper reviews current multiple sclerosis (MS) treatments and explores the potential benefits of combining drugs with known or theoretical efficacy.
  • It discusses the rationale for combination therapy and its potential clinical applications in MS management.
  • The review also considers challenges in designing clinical trials for combination therapies, particularly the use of placebo in relapsing MS.

Related Experiment Videos

Impact:

  • Combination therapy presents a viable strategy to achieve greater efficacy in multiple sclerosis treatment.
  • This approach may offer improved disease control for patients unresponsive to current therapies.